PSP Research offers customized investment advisory solutions to corporations and businesses. They work with clients to identify investment goals, risk tolerance, and financial situations to create a portfolio strategy. PSP Research constructs portfolios primarily focused on the biotechnology and pharmaceutical sector, using exchange-traded funds, individual stocks, bonds, or options contracts. They monitor portfolios and may re-allocate positions to meet client objectives or due to market conditions.
Fee Structure
PSP Research's investment advisory fees are based on the value of the assets they manage and are paid quarterly in advance. The fees can range up to 2.00% annually, depending on the complexity of the services, the amount of assets managed, and the overall relationship with PSP Research. Fees may be negotiable.